Journal of Nuclear Medicine: 58 (11)

November 1, 2017; Volume 58,Issue 11

Cover image

FEATURED ARTICLE

Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer. Sarah Cheal et al. See page 1735.

CXCR4-targeted imaging: can PET/MRI pinpoint renal allograft infection? Thorsten Derlin et al. See page 1831.

PET and circulating DNA biomarkers: new insights into tumor biologic behavior in NSCLC? Silvia Morbelli et al. See page 1764.

In this issue

Issue highlights

Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer
Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non–Small Cell Lung Cancer: ¹⁸F-FDG PET/CT Study
Clinical Use and Utility of Amyloid Imaging
More α Than β for Prostate Cancer?

⁶⁸Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region
Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention
First-in-Humans Imaging with ⁸⁹Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a ⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

More...

Main menu

User menu

Search

Table of Contents

Cover image

In this issue

Issue highlights

Jump to